TETRAGRAPH® | EMG BASED QUANTITATIVE NEUROMUSCULAR MONITOR

A world without anesthesia-related complications

Read more

A Swedish medical technology company

Senzime develops and markets CE-marked and FDA-approved medical technology systems, powered by unique algorithms and disposable sensors that assess the patient’s muscle function before, during and after anaesthesia.

Our vision is a world without anesthesia-related complications

CEO Statement

Growth in the first quarter was clear. Total sales growth was 64 percent, with the U.S. accounting for the largest increase, 109 percent year-over-year, and Europe up 36 percent. Sensor sales increased by 44 percent during the quarter compared to the same period in 2021.

Pia Renaudin
CEO

Press Releases

Learn more

Do you want to know more?

Contact us for more information.